Coumarin, anthroquinone and stilbene derivatives with anticholinesterase activity

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 63, Issue 5-6, 2008, Pages 366-370

  Orhan, Ilkay ^a   Tosun, Fatma ^a   Şener, Bilge ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Coumarin

Indexed keywords

ALOE; APIACEAE; HERACLEUM;

ANTHRAQUINONE DERIVATIVE; BERGAPTEN; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; COUMARIN DERIVATIVE; DRUG DERIVATIVE; METHOXSALEN; MONOAMINE OXIDASE INHIBITOR; PSORALEN DERIVATIVE; RHAPONTIN; SCOPOLETIN; STILBENE DERIVATIVE;

ARTICLE; CHEMISTRY; GINKGO BILOBA; HERACLEUM; METABOLISM;

ANTHRAQUINONES; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; COUMARINS; GINKGO BILOBA; HERACLEUM; METHOXSALEN; MONOAMINE OXIDASE INHIBITORS; PSORALENS; SCOPOLETIN; STILBENES;

EID: 48249087702     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2008-5-610     Document Type: Article

References (21)

1. Borges F., Roleira F., Milhazes N., Santana L., and Uriarte E. (2005), Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr. Med. Chem. 12, 887-916.
2. Bruehlmann C., Ooms F., Carrupt P. A., Testa B., Catto M., Leonetti F., Altomare C., and Carotti A. (2001), Coumarin derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J. Med. Chem. 44, 3195-3198.
3. Cummings J. L. (2004), Alzheimer's disease. New Eng. J. Med. 351, 56-67.
4. Ellman G. L., Courtney K. D., Andres V., and Featherstone R. M. (1961), A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
5. Francis P. T., Nordberg A., and Arnold S. E. (2005), A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? Trends Pharmacol. Sci. 26, 105-110.
6. Kang S. Y., Lee K. Y., Park M. J., Kim Y. C., Markelonis G. T., Oh T. H., and Kim Y. C. (2003), Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol. Learn. Memory 79, 11-18.
7. Kim D. H., Kim D. Y., Kim Y. C., Jung J. W., Lee S., Yoon B. H., Cheong J. H., Kim Y. S., Kang S. S., Ko K. H., and Ryu J. H. (2007), Nodakenin, a coumarin compound, ameliorates scopolamine-induced memory disruption in mice. Life Sci. 80, 1944-1950.
8. Mantle D., Pickering A. T., and Perry E. K. (2000), Medicinal plant extracts for the treatment of dementia. CNS Drugs 13, 201-213.
9. Mattson M. P. (2004), Pathways towards and away from Alzheimer's disease. Nature 430, 631-639.
10. O'Kennedy R. and Thornes R. D. (1997), Coumarins: Biology, Applications and Mode of Action. Wiley & Sons, Chichester.
11. Orhan I., Şener B., Choudhary M. I., and Khalid A. (2004), Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J. Ethnopharmacol. 91, 57-60.
12. Orhan I., Kartal M., Naz Q, Yilmaz G., Kan Y., Konuklugil B., Şener B., and Choudhary M. I. (2007), Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species. Food Chem. 103, 1247-1254.
13. Rollinger J. M., Hornick A., Langer T., Stuppner H., and Prast H. (2004), Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. J. Med. Chem. 47, 6248-6254.
14. Scarpini E., Scheltens P., and Feldman H. (2003), Treatment of Alzheimer's disease: current status and new perspectives. Lancet 2, 539-547.
15. Sonboli A., Azizian D., Yousefzadi M., Kanani M. R., and Mehrabian A. R. (2007), Volatile constituents and antimicrobial activity of the essential oil of Tetrataenium lasiopetalum (Apiaceae) from Iran. Flav. Fragr. J. 22, 119-122.
16. Souri E., Farsam H., Sarkheil P., and Ebadi F. (2004), Antioxidant activity of some furanocoumarins isolated from Heracleum persicum. Pharm. Biol. 42, 396-399.
17. Sung S. H., Kang S. Y., Lee K. Y., Park M. J., Kim J. H., Park J. H., Kim Y. C., Kim J., and Kim Y. C. (2002), (+)-α-Viniferin, a stilbene trimer from Caragana chamlague. Biol. Pharm. Bull. 25, 125-127.
18. Tosun F. and Akyüz Ç. (2007), Furanocoumarins from Heracleum crenatifolium Boiss. Planta Med. 73, 960.
19. Tosun F., Kizilay-Akyüz Ç, Erol K., Kiliç F. S., Kürkçüoǧlu M., and Başer K. H. C. (2008), Anticonvulsant activity of furanocoumarins and the essential oil obtained from the fruits of Heracleum crenatifolium. Food Chem. 107, 990-993.
20. Urbain A., Marston A., and Hostettman K. (2005), Coumarins from Peucedanum ostruthium as inhibitors of acetylcholinesterase. Pharm. Biol. 43, 647-650.
21. Yun B. S., Lee I. K., Ryoo I. J., and Yoo I. D. (2001), Coumarins with monoamine oxidase inhibitory activity and antioxidative coumarino-lignans from Hibiscus syriacus. J. Nat. Prod. 64, 1238-1240.